Over the past decade, researchers around the world have published more than 32000 studies on the science of cannabis and cannabinoids, according to a report from NORML. Additionally, 2023 marked the third consecutive year in which scientists published more than 4 articles specific to cannabis, cannabinoids, and their varied effects.
This development stands in stark contrast to most political arguments against cannabis policy reforms, which typically argue that more research into the potential dangers of cannabis is needed before easing restrictions on the plant.
“Scientists’ desire to study cannabis has grown exponentially in recent years,” said Paul Armentano, deputy director of NORML, in a recent blog post on the policy advocacy group’s website.
“It's time for politicians and others to stop evaluating cannabis through the lens of 'what we don't know' and instead start engaging in evidence-based discussions regarding marijuana and reform policies cannabis that reflect everything we know.” – Armentano, via NORML
NORML, founded in 1970, is the oldest and largest organization in the United States advocating for the legalization of cannabis.
Some of the notable cannabis studies published in 2023 have supported the following claims:
- People who use cannabis to aid their sleep tend to no longer rely on over-the-counter sleeping pills.
- The cannabis users who contracted COVID-19 experienced reduced mortality and better outcomes compared to non-consumers.
- Cannabis appears to have a positive impact on the sex lives of those who consume it.
Meanwhile, researchers have also examined the societal effects of reforming cannabis laws at the local and state level, including a recent study that found that the average home value in states with cannabis laws at adult use surpassed that of states where cannabis is illegal.